跳转至内容
Merck
CN
  • ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A.

ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A.

Archives of ophthalmology (Chicago, Ill. : 1960) (2012-02-15)
Eliot L Berson, Bernard Rosner, Michael A Sandberg, Carol Weigel-DiFranco, Walter C Willett
摘要

To evaluate whether a diet high in long chain ω-3 fatty acids can slow the rate of visual acuity loss among patients with retinitis pigmentosa receiving vitamin A palmitate. We calculated dietary intake from questionnaires completed annually by 357 adult patients from 3 randomized trials who were all receiving vitamin A, 15 000 IU/d, for 4 to 6 years. Rates of visual acuity decline were compared between those with high (≥0.20 g/d) vs low (<0.20 g/d) ω-3 intake. Analyses took age into account. Mean rates of decline of acuity were slower among those with high ω-3 intake: Early Treatment Diabetic Retinopathy Study distance acuity: high intake=0.59 letter per year, low intake=1.00 letter per year,P=.001; Snellen retinal acuity: high intake=1.5% per year, low intake=2.8% per year, P=.03. We conclude that mean annual rates of decline in distance and retinal visual acuities in adults with retinitis pigmentosa receiving vitamin A, 15 000 IU/d,are slower over 4 to 6 years among those consuming a diet rich in ω-3 fatty acids. To our knowledge, this is the first report that nutritional intake can modify the rate of decline of visual acuity in retinitis pigmentosa.

材料
货号
品牌
产品描述

Supelco
视黄醇(维生素A)棕榈酸酯 CRM, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
视黄醇(维生素A)棕榈酸酯 CRM, potency: ≥1,700,000 USP units per g
Supelco
视黄醇棕榈酸酯, analytical standard
Sigma-Aldrich
视黄醇(维生素A)棕榈酸酯 CRM, Type IV, ~1,800,000 USP units/g, oil